The Fraunhofer Center for Molecular Biotechnology ("CMB") in Newark ... scalable "factory" that uses natural (non-genetically-modified) green plants to efficiently produce large quantities of vaccines ...

For years, scientists at the Fraunhofer USA Center for Molecular Biotechnology have been infusing plants with genes to produce proteins that could one day immunize people from diseases such as ...

Fraunhofer Center for Molecular Biotechnology in Newark ... The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies to assist the diagnosis, ...

The biotech also cites Fraunhofer's website, which advertises its ability to develop biopharmaceuticals using "a proprietary plant-based expression platform." And it notes a 2014 annual report ...

Plants cannot thrive without ... The researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart, Germany are working at alternatives.

Fraunhofer CMB’s new ... The Center conducts research in the area of plant biotechnology, utilizing new, cutting edge technologies to assist with the diagnosis, prevention and treatment of ...

Plant-based product developer iBio, which announced just before Labor Day a deal with GE Healthcare and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine ...

DARPA awarded $12 million to Fraunhofer USA Center for Molecular Biotechnology (CMB) and iBioPharma to accelerate pharmaceutical manufacture. The goal is to demonstrate that CMB’s plant-based ...

The pilot plant is part of the ETAMAX ... Ursula Schließmann, head of department at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB). Because the microorganisms ...

Researchers at the Fraunhofer Institute for Environmental, Energy and Safety Technology have developed a "biobattery" in the form of a highly efficient biogas plant that can turn raw materials ...